Breast cancer stem cell hypothesis: Clinical relevance (answering breast cancer clinical features)

Clinical and Translational Oncology

Volumn 12, Issue 6, 2010, Pages 395-400

  Salas, Nuria Rodríguez ^a   González, Enrique González ^b   Amat, Carlos Gamallo ^c  

^a HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^b Universidad Francisco de Vitoria   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Asymmetric division; Breast cancer; Cancer stem cell; Hedgehog; Mammosphere; Notch; Self renewal; Wnt

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; BRCA1 PROTEIN; BREAST CANCER RESISTANCE PROTEIN; CD24 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ETAMSYLATE; EVEROLIMUS; HERMES ANTIGEN; LAPATINIB; PROTEINASE INHIBITOR; TEMSIROLIMUS; UNCLASSIFIED DRUG;

BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RELAPSE; CANCER STEM CELL; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CLINICAL TRIAL; DORMANCY; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; EARLY CANCER; EPITHELIUM CELL; ERADICATION THERAPY; EXPERIMENTAL MODEL; GENE MUTATION; HUMAN; HYPOTHESIS; IN VITRO STUDY; MALIGNANT TRANSFORMATION; METASTASIS; MOLECULARLY TARGETED THERAPY; NONHUMAN; PROTEIN FUNCTION; REVIEW; TREATMENT RESPONSE; TUMOR DIFFERENTIATION; BIOLOGICAL MODEL; BREAST NEOPLASMS; CARCINOMA; CELL SEPARATION; CELL TRANSFORMATION; CLASSIFICATION; CYTOLOGY; FEMALE; PATHOLOGY; PHYSIOLOGY; PROCEDURES; THEORETICAL MODEL;

BREAST NEOPLASMS; CARCINOMA; CELL SEPARATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; NEOPLASTIC STEM CELLS;

EID: 77955943275     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-010-0526-4     Document Type: Review

References (35)

1. Wicha MS, Liu S, Dontu G (2006) Cancer stem cells: an old idea - a paradigm shift. Cancer Res 66:1883-1890
2. Cicalese A, Bonizzi G, Pasi CE et al (2009) The tumor suppressor p53 regulates polarity of selfrenewing divisions in mammary stem cells. Cell 138:1083-1095
3. Stingl J, Eirew P, Ricketson I et al (2006) Purification and unique properties of mammary epithelial stem cells. Nature 439:993-997
4. Dontu G, Abdallah WM, Foley JM et al (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17:1253-1270
5. Villadsen R, Fridriksdottir AJ, Ronnov-Jessen L et al (2007) Evidence for a stem cell hierarchy in the adult human breast. J Cell Biol 177:87-101
6. Shackleton M, Vaillant F, Simpson KJ et al (2006) Generation of a functional mammary gland from a single stem cell. Nature 439:84-88
7. Vaillant F, Asselin-Labat ML, Shackleton M et al (2007) The emerging picture of the mouse mammary stem cell. Stem Cell Rev 3:114-123
8. Dontu G, Abdallah WM, Foley JM et al (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17:1253-1270
9. Liu S, Dontu G, Mantle ID et al (2006) Hedgehog signalling and BMI-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66:6063-6071
10. César Cobaleda C, Cruz JJ, González-Sarmiento R et al (2008) The emerging picture of human breast cancer: as a stem cell-based disease. StemCell Rev 4:67-79
11. Stingl J, Caldas C (2007) Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer 7:791-799
12. Li Y, Welm B, Podsypanina K et al (2003) Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci U S A 100:15853-15858
13. Russo J, Tay LK, Russo IH (1982) Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 2:5-73
14. Liu S, Ginestier C, Charafe-Jauffret E et al (2008) BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci USA 105:1680-1685
15. Holst CR, Nuovo GJ, Esteller M et al (2003) Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res 63:1596-1601
16. Polyak K (2007) Breast cancer stem cells: a case of mistaken identity? Stem Cell Rev 3(2):107-109
17. Ponti D, Costa A, Zaffaroni N et al (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65:5506-5511
18. Kim M, Turnquist H, Jackson J et al (2002) The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res 8:22-28
19. Ginestier C, Hur MH, Charafe-Jauffret E et al (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1:555-567
20. Al-Hajj M, Wicha MS, Benito-Hernandez A et al (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100:3983-3988
21. Pece S,Tosoni D, Confalonieri S et al (2010) Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 140:62-73
22. Blau HM, Brazelton TR, Weimann JM (2001) The evolving concept of a stem cell: entity or function? Cell 105:829-841
23. Gonzalez-Sarmiento R, Perez-Losada J (2008) Breast cancer as a stem cell disease. Curr Stem Cell Res Ther 3:55-65
24. Li X, Lewis MT, Huang J et al (2008) Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100(9):67
25. Bunting KD, Lindahl R, Townsend AJ (1994) Oxazaphosphorine-specific resistance in human MCF-7 breast carcinoma cell lines expressing transfected rat class 3 aldehyde dehydrogenase. J Biol Chem 269:23197-23203
26. Phillips TM, McBride WH, Pajonk F (2006) The response of CD24(-/low)/CD44+ breast cancerinitiating cells to radiation. J Natl Cancer Inst 98:1777-1785
27. Koji Morimoto, Seung Jin Kim, Tomonori Tanei et al (2009) Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression. Cancer Sci 100:1062-1068
28. Resetkova E, Reis-Filho J, Jain R et al (2009) Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment. Breast Cancer Res Treat DOI 10.1007/s10549-009-0619-623
29. Tomonori Tanei, Koji Morimoto, Kenzo Shimazu et al (2009) Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin Cancer Res 15(12):4234-4241
30. Korkaya H, Paulson A, Iovino F et al (2008) HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene 27:6120-6130
31. Li X, Lewis MT, Huang J et al (2008) Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100(9):672
32. Nickoloff BJ, Osborne BA, Miele L (2003) Notch signalling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene 22:6598-6608
33. Hatsell S, Frost AR (2007) Hedgehog signaling in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 12:163-173
34. Saal LH, Gruvberger-Saal SK, Persson C et al (2008) Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nat Genet 40:102-107
35. Wang W, El-Deiry WS (2008) Restoration of p53 to limit tumor growth. Curr Opin Oncol 20:90-96